​

Johnson & Johnson (JNJ) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

JNJ Stock Forecast

Johnson & Johnson (JNJ) stock forecast, based on 39 Wall Street analysts, predicts a 12-month average price target of $229.33, with a high of $265.00 and a low of $190.00. This represents a -5.25% decline from the last price of $242.04.

$100 $140 $180 $220 $260 $300 High: $265 Avg: $229.33 Low: $190 Last Closed Price: $242.04

JNJ Stock Rating

Johnson & Johnson stock's rating consensus is Buy, based on 39 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 20 Buy (51.28%), 16 Hold (41.03%), 3 Sell (7.69%), and 0 Strong Sell (0.00%).

Buy
Total 39 3 16 20 0 Strong Sell Sell Hold Buy Strong Buy

JNJ Price Target Upside V Benchmarks

TypeNameUpside
StockJohnson & Johnson-5.25%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks1.85%

Price Target Trends

1M3M12M
# Anlaysts-1330
Avg Price Target-$235.15$217.17
Last Closing Price$242.04$242.04$242.04
Upside/Downside--2.85%-10.28%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 265910-125
Feb, 265910-125
Jan, 264911-125
Dec, 254911-125
Nov, 253911-124
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 03, 2026RBC Capital$255.00$233.359.28%5.35%
Jan 28, 2026Terrance FlynnMorgan Stanley$262.00$224.4416.73%8.25%
Jan 27, 2026Ilya ZubkovLoop Capital Markets$220.00$225.16-2.29%-9.11%
Jan 23, 2026Vamil DivanGuggenheim$240.00$218.499.84%-0.84%
Jan 22, 2026Scotiabank$265.00$220.1820.36%9.49%
Jan 22, 2026Terence FlynnMorgan Stanley$200.00$220.37-9.24%-17.37%
Jan 22, 2026Rick WiseStifel Nicolaus$220.00$218.010.91%-9.11%
Jan 22, 2026Asad HaiderGoldman Sachs$250.00$218.0114.67%3.29%
Jan 22, 2026Wells Fargo$240.00$218.0110.09%-0.84%
Jan 09, 2026Lee HambrightBernstein$208.00$205.751.09%-14.06%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 02, 2026Bank of America SecuritiesNeutralNeutralhold
Feb 03, 2026RBC CapitalOutperformOutperformhold
Jan 28, 2026Morgan StanleyUnderperformOverweightupgrade
Jan 23, 2026GuggenheimBuyBuyhold
Jan 22, 2026ScotiabankOutperformOutperformhold
Jan 22, 2026Cowen & Co.BuyBuyhold
Jan 22, 2026Goldman SachsBuyBuyhold
Jan 22, 2026CitigroupBuyBuyhold
Jan 22, 2026Wells FargoOverweightOverweighthold
Jan 09, 2026BernsteinMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 $14 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$7.93$6.83$13.88$5.84$11.03----
Avg Forecast$9.83$10.05$9.92$9.95$10.57$11.04$11.53$12.21$12.80
High Forecast$9.94$10.16$9.95$10.09$10.62$11.42$12.49$12.51$13.11
Low Forecast$9.75$9.96$9.91$9.90$10.51$10.85$10.56$11.99$12.57
Surprise %-19.33%-32.04%39.92%-41.31%4.35%----

Revenue Forecast

$75B $82B $89B $96B $103B $110B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$78.74B$79.99B$85.16B$88.82B$94.19B----
Avg Forecast$94.45B$95.02B$84.75B$88.78B$90.30B$93.55B$97.02B$101.93B$106.16B
High Forecast$95.24B$95.88B$84.79B$89.21B$91.53B$94.48B$97.31B$103.85B$108.15B
Low Forecast$93.83B$94.42B$84.73B$88.58B$89.79B$92.09B$96.74B$100.50B$104.67B
Surprise %-16.63%-15.82%0.49%0.05%4.31%----

Net Income Forecast

$10B $16B $22B $28B $34B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$20.88B$17.94B$35.15B$14.07B$26.80B----
Avg Forecast$17.26B$18.98B$13.33B$25.59B$27.05B$28.52B$29.51B$31.26B$32.77B
High Forecast$20.71B$22.78B$15.99B$25.83B$27.19B$29.24B$31.98B$32.03B$33.57B
Low Forecast$13.81B$15.19B$10.66B$25.35B$26.91B$27.79B$27.05B$30.69B$32.18B
Surprise %20.98%-5.49%163.79%-45.03%-0.91%----

JNJ Forecast FAQ

Is Johnson & Johnson stock a buy?

Johnson & Johnson stock has a consensus rating of Buy, based on 39 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 20 Buy, 16 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Johnson & Johnson is a favorable investment for most analysts.

What is Johnson & Johnson's price target?

Johnson & Johnson's price target, set by 39 Wall Street analysts, averages $229.33 over the next 12 months. The price target range spans from $190 at the low end to $265 at the high end, suggesting a potential -5.25% change from the previous closing price of $242.04.

How does Johnson & Johnson stock forecast compare to its benchmarks?

Johnson & Johnson's stock forecast shows a -5.25% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the drug manufacturers - general stocks industry (1.85%).

What is the breakdown of analyst ratings for Johnson & Johnson over the past three months?

  • March 2026: 20.00% Strong Buy, 36.00% Buy, 40.00% Hold, 0% Sell, 4.00% Strong Sell.
  • February 2026: 20.00% Strong Buy, 36.00% Buy, 40.00% Hold, 0% Sell, 4.00% Strong Sell.
  • January 2026: 16.00% Strong Buy, 36.00% Buy, 44.00% Hold, 0% Sell, 4.00% Strong Sell.

What is Johnson & Johnson’s EPS forecast?

Johnson & Johnson's average annual EPS forecast for its fiscal year ending in December 2026 is $11.04, marking a 0.09% increase from the reported $11.03 in 2025. Estimates for the following years are $11.53 in 2027, $12.21 in 2028, and $12.8 in 2029.

What is Johnson & Johnson’s revenue forecast?

Johnson & Johnson's average annual revenue forecast for its fiscal year ending in December 2026 is $93.55B, reflecting a -0.69% decrease from the reported $94.19B in 2025. The forecast for 2027 is $97.02B, followed by $101.93B for 2028, and $106.16B for 2029.

What is Johnson & Johnson’s net income forecast?

Johnson & Johnson's net income forecast for the fiscal year ending in December 2026 stands at $28.52B, representing an 6.39% increase from the reported $26.8B in 2025. Projections indicate $29.51B in 2027, $31.26B in 2028, and $32.77B in 2029.